Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward

D Krug, R Baumann, SE Combs, MN Duma… - Strahlentherapie und …, 2021 - Springer
Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy
after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST …

[HTML][HTML] COVID-19: Global radiation oncology's targeted response for pandemic preparedness

R Simcock, TV Thomas, C Estes, AR Filippi… - Clinical and …, 2020 - Elsevier
As the global COVID-19 pandemic escalates there is a need within radiation oncology to
work to support our patients in the best way possible. Measures are required to reduce …

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 …

NML Battisti, AR Mislang, L Cooper… - Journal of geriatric …, 2020 - Elsevier
The COVID-19 pandemic poses a barrier to equal and evidence-based management of
cancer in older adults. The International Society of Geriatric Oncology (SIOG) formed a panel …

Male breast cancer in the United States: treatment patterns and prognostic factors in the 21st century

S Yadav, D Karam, I Bin Riaz, H Xie, U Durani… - Cancer, 2020 - Wiley Online Library
Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …

Pre‐treatment systemic immune‐inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy

L Chen, X Kong, Z Wang, X Wang… - Journal of cellular …, 2020 - Wiley Online Library
The systemic immune‐inflammation index (SII= N× P/L) based on neutrophil (N), platelet (P)
and lymphocyte (L) counts is used to predict the survival of patients with malignant tumours …

[HTML][HTML] Real de-escalation or escalation in disguise?

M Banys-Paluchowski, IT Rubio, N Ditsch, D Krug… - The Breast, 2023 - Elsevier
The past two decades have seen an unprecedented trend towards de-escalation of surgical
therapy in the setting of early BC, the most prominent examples being the reduction of re …

An aggregated comorbidity measure based on history of filled drug prescriptions: development and evaluation in two separate cohorts

R Gedeborg, M Sund, M Lambe, A Plym… - …, 2021 - journals.lww.com
Background: The ability to account for comorbidity when estimating survival in a population
diagnosed with cancer could be improved by using a drug comorbidity index based on filled …

Older cancer patients and COVID‐19 outbreak: practical considerations and recommendations

A Brunello, A Galiano, S Finotto, S Monfardini… - Cancer …, 2020 - Wiley Online Library
Since the COVID‐19 outbreak started, it has been affecting mainly older individuals. Among
the most vulnerable older individuals are those with cancer. Many published guidelines and …

[PDF][PDF] Breast cancer in geriatric patients: current landscape and future prospects

H Abdel-Razeq, F Abu Rous, F Abuhijla… - … Interventions in Aging, 2022 - Taylor & Francis
Breast cancer is the most common cancer diagnosed among women worldwide and more
than half are diagnosed above the age of 60 years. Life expectancy is increasing and the …

Comparing local and systemic control between partial-and whole-breast radiotherapy in low-risk breast cancer—A meta-analysis of randomized trials

J Haussmann, W Budach, V Strnad, S Corradini… - Cancers, 2021 - mdpi.com
Simple Summary This meta-analysis compares the treatment results of partial-breast
radiotherapy to those of whole-breast radiotherapy after breast conserving surgery in early …